OOIR: Observatory of International Research

Papers

(The median citation count of Clinical Microbiology Reviews is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
New β-Lactam–β-Lactamase Inhibitor Combinations	292
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection	233
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders	211
Remdesivir against COVID-19 and Other Viral Diseases	192
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection	148
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis	141
Pathogenesis of Gram-Negative Bacteremia	125
Microsporidiosis in Humans	113
Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria	110
Yersinia pestis: the Natural History of Plague	104
The Changing Face of the Family Enterobacteriaceae (Order: “ Enterobacterales ”): New Members, Taxonomic Issues, Geographic Expansion, and	102
Advances in the Microbiology of Stenotrophomonas maltophilia	101
Evolutionary Pathways and Trajectories in Antibiotic Resistance	100
Viral Respiratory Pathogens and Lung Injury	93
Epidemiology, Pathophysiology, Diagnosis, and Management of Cerebral Toxoplasmosis	92
Human Listeriosis	75
Pathogenesis of Respiratory Viral and Fungal Coinfections	74
COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes	74
Laboratory Diagnosis of Lyme Borreliosis	73
Mechanisms of Drug-Induced Tolerance in Mycobacterium tuberculosis	72
Giardia duodenalis: Biology and Pathogenesis	71
SARS-CoV-2 Antiviral Therapy	70
Klebsiella oxytoca Complex: Update on Taxonomy, Antimicrobial Resistance, and Virulence	65
Molecular Epidemiology of Human Cryptosporidiosis in Low- and Middle-Income Countries	62
Progress and Challenges in the Prevention, Diagnosis, and Management of Cytomegalovirus Infection in Transplantation	57

Machine Learning for Antimicrobial Resistance Prediction: Current Practice, Limitations, and Clinical Perspective	56
Environmental, Microbiological, and Immunological Features of Bacterial Biofilms Associated with Implanted Medical Devices	55
Staphylococcus lugdunensis: a Skin Commensal with Invasive Pathogenic Potential	50
Interplay between Candida albicans and Lactic Acid Bacteria in the Gastrointestinal Tract: Impact on Colonization Resistance, Microbial Carriage, Opportunistic Infection, and Host Immunity	49
The Five Ds of Outpatient Antibiotic Stewardship for Urinary Tract Infections	49
Helicobacter pylori Infection, Its Laboratory Diagnosis, and Antimicrobial Resistance: a Perspective of Clinical Relevance	47
Antiviral Approaches against Influenza Virus	47
Updated Review onNocardiaSpecies: 2006–2021	46
Sensitivity to Vaccines, Therapeutic Antibodies, and Viral Entry Inhibitors and Advances To Counter the SARS-CoV-2 Omicron Variant	46
Staphylococcus aureus in Agriculture: Lessons in Evolution from a Multispecies Pathogen	44
SARS-CoV-2 and Health Care Worker Protection in Low-Risk Settings: a Review of Modes of Transmission and a Novel Airborne Model Involving Inhalable Particles	41
Paracoccidioidomycosis: Current Status and Future Trends	39
Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection	39
Monkeypox Virus Infections in Humans	38
Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation	37
Understanding the Impact of Resistance to Influenza Antivirals	37
State of the Art in the Culture of the Human Microbiota: New Interests and Strategies	36
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies	36
Canine and Feline Parasitology: Analogies, Differences, and Relevance for Human Health	35
Digital PCR Applications in the SARS-CoV-2/COVID-19 Era: a Roadmap for Future Outbreaks	35
SARS-CoV-2 Infection and Lung Regeneration	32
Aspergillus terreus Species Complex	31
Echinococcoses in Iran, Turkey, and Pakistan: Old Diseases in the New Millennium	31
The Microbial Etiology of Community-Acquired Pneumonia in Adults: from Classical Bacteriology to Host Transcriptional Signatures	30
Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use	29
Clinical and Public Health Implications of Human T-Lymphotropic Virus Type 1 Infection	29
An Overlooked and Underrated Endemic Mycosis—Talaromycosis and the Pathogenic Fungus Talaromyces marneffei	28
Group B Streptococcal Neonatal Meningitis	28
Diagnosis, Management, and Future Control of Cholera	28
Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis	28
Klebsiella pneumoniae carbapenemase variants: the new threat to global public health	27
Erratum for Yahav et al., “New β-Lactam–β-Lactamase Inhibitor Combinations”	25
Human and Animal Fascioliasis: Origins and Worldwide Evolving Scenario	25
Candidate Phyla Radiation, an Underappreciated Division of the Human Microbiome, and Its Impact on Health and Disease	23
Erratum for Ramasamy and Subbian, “Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis”	23
Practical Guidance for Clinical Microbiology Laboratories: Diagnosis of Ocular Infections	23
Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections	22
Reassessment of Historical Clinical Trials Supports the Effectiveness of Phage Therapy	22
Class C β-Lactamases: Molecular Characteristics	21
Natural-Product-Based Solutions for Tropical Infectious Diseases	21
Type I Natural Killer T Cells as Key Regulators of the Immune Response to Infectious Diseases	19
Intestinal Bacteriophage Therapy: Looking for Optimal Efficacy	19
Osteoarticular Mycoses	18
Mesenchymal Stromal Cells: an Antimicrobial and Host-Directed Therapy for Complex Infectious Diseases	18
Fungal Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management	17
Bacillus cereus Invasive Infections in Preterm Neonates: an Up-to-Date Review of the Literature	17
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond	17
Controlled Human Infection Models To Accelerate Vaccine Development	17
Clinical Laboratory Biosafety Gaps: Lessons Learned from Past Outbreaks Reveal a Path to a Safer Future	16
Agnostic Sequencing for Detection of Viral Pathogens	15

Invasive fusariosis	15
Transmission of Infections during Cardiopulmonary Resuscitation	14
The Changing Paradigm of Drug-Resistant Tuberculosis Treatment: Successes, Pitfalls, and Future Perspectives	14
The Standardization and Control of Serology and Nucleic Acid Testing for Infectious Diseases	14
Biofilm antimicrobial susceptibility testing: where are we and where could we be going?	13
Congenital Syphilis: a Review of Global Epidemiology	12
Membrane Technology for Rapid Point-of-Care Diagnostics for Parasitic Neglected Tropical Diseases	12
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells	11
MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets	11
Bioengineering Strategies for Developing Vaccines against Respiratory Viral Diseases	11
Laboratory Detection of Malaria Antigens: a Strong Tool for Malaria Research, Diagnosis, and Epidemiology	11
Clostridioides difficile infection: history, epidemiology, risk factors, prevention, clinical manifestations, treatment, and future options	11
Trained Immunity as a Preventive Measure for Surgical Site Infections	11